Similar content being viewed by others Log in or create a free account to read this content Gain free access to this article, as well as selected content from this journal and more on nature.com or References Stoffel M, Espinosa R, Le Beau MM, Bell GI
For 2,567 semaglutide users who stopped treatment, 33% regained weight, 32% maintained weight loss, and 35% continued losing weight
As such, both the generation and function of active GLP-1 have become important aspects of type 2 diabetes (T2D) research 2
Chronic kidney disease (CKD), particularly in later stages, is a recognized cause of hypercobalaminemia
This advanced formula is intended to replenish glutathione levels in the body, which may have been depleted due to stress, ageing, poor diet, or environmental toxins
Until more research is available, the use of these drugs in T1D should be done carefully, with a thorough discussion with patients about potential risks and benefits of this approach